Sun Pharma concludes ESOP plan of former Ranbaxy employees and closes Trust

Enters into licensing agreement with Aclaris Therapeutics, a clinical-stage bio-pharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases

Subscribe To Our Free Newsletter